Research Division
Stephen Gillespie joined distinguished international colleagues on a European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Symposium “Tuberculosis: Bringing new science to diagnostics”. Speaking…
Globally, Tuberculosis (TB) is the leading cause of death from a single infectious disease agent. Our sustained research in St Andrews over the last 10 years (on the disease and the pathogen responsible) has developed…
The Arclight Project using funds from a GCRF grant have recently revamped their website – http://med.st-andrews.ac.uk/arclight/. This has coincided with release of instructional videos on the site as well as the…
The St Andrews tuberculosis research group together with global health partners have won a €4.9 million grant from the European Developing Countries Clinical Trials Partnership (EDCTP). Led by…
Dr Muge Cevik from the School of Medicine at the University of St Andrews has been appointed to support the UK Government’s scientific advisory group. She has been co-opted to NERVTAG (New and Emerging Respiratory…
It is inexcusable to open nonessential services for adults this summer if it forces students to remain at home even part-time this fall. As communities and families navigate the complicated issues around reopening…
Dr Devesh Dhasmana, the lead for NHS Fife in the national clinical RECOVERY trial which aims to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19 has recently been…
Dr Derek Sloan is working closely with colleagues at the Infectious Diseases Institute at Makerere University in Kampala, Uganda, in order to develop a series of adverts and programmes for Ugandan television about…
During April and May 2020, ‘three ask the expert’ sessions were held for staff to answer their queries on Covid-19. These were introduced by Prof Stephen Gethins. The panel included Prof Stephen Gillespie and Dr Devesh…
From the 23rd-27th February 2020, Damilola Oresegun, PhD student with Dr Janet Cox Singh attended the Molecular Approaches to Malaria (MAM) conference in Lorne, Australia. Taking place every 4 years, MAM aims to…